3,844 Shares in CVS Health Corporation (NYSE:CVS) Purchased by Callan Capital LLC

Callan Capital LLC bought a new position in CVS Health Corporation (NYSE:CVS - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,844 shares of the pharmacy operator's stock, valued at approximately $260,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in CVS. TD Private Client Wealth LLC raised its holdings in CVS Health by 152.4% in the 1st quarter. TD Private Client Wealth LLC now owns 78,914 shares of the pharmacy operator's stock valued at $5,346,000 after buying an additional 47,649 shares during the last quarter. Envestnet Asset Management Inc. raised its holdings in CVS Health by 21.8% in the 1st quarter. Envestnet Asset Management Inc. now owns 1,863,078 shares of the pharmacy operator's stock valued at $126,224,000 after buying an additional 333,364 shares during the last quarter. Hexagon Capital Partners LLC raised its holdings in CVS Health by 10.1% in the 1st quarter. Hexagon Capital Partners LLC now owns 7,353 shares of the pharmacy operator's stock valued at $498,000 after buying an additional 674 shares during the last quarter. US Asset Management LLC bought a new position in CVS Health in the 1st quarter valued at approximately $294,000. Finally, Sierra Ocean LLC raised its holdings in CVS Health by 584.8% in the 1st quarter. Sierra Ocean LLC now owns 719 shares of the pharmacy operator's stock valued at $49,000 after buying an additional 614 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Down 0.4%

NYSE CVS traded down $0.29 during mid-day trading on Wednesday, hitting $66.65. The company's stock had a trading volume of 6,329,968 shares, compared to its average volume of 10,809,033. The company's 50 day simple moving average is $65.18 and its 200 day simple moving average is $61.90. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $84.31 billion, a price-to-earnings ratio of 15.91, a PEG ratio of 0.95 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.31 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Tuesday, July 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.99%. The ex-dividend date of this dividend is Tuesday, July 22nd. CVS Health's dividend payout ratio is 63.48%.

Analysts Set New Price Targets

Several research analysts have issued reports on CVS shares. Royal Bank Of Canada raised their price target on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Cowen restated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Truist Financial raised their price target on shares of CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Monday, May 12th. Jefferies Financial Group raised their price target on shares of CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Finally, Mizuho raised their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $75.06.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the business's stock in a transaction on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the acquisition, the director directly owned 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.22% of the stock is owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.